Lallemand Pharma

Lallemand Pharma AG, is a company dedicated to the development and commercialization of respiratory products having the status of drug or medical device.
Since 2007, Lallemand Pharma markets drugs containing as an active principle, a bacterial lysate called PMBL®. Products are sold in several countries under different brands Ismigen®, Immubron®, Respibron® and PIR-05®. PMBL based products are...